Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01754207 · ClinicalTrials.gov registry record · NA
Evaluation of the 755nm Alexandrite Laser for the Treatment of Tattoos
A NA study of Tattoos, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01754207: Completed NA study of Tattoos, sponsored by Cynosure.
NCT01754207 is a NA study of Tattoos that has completed, run by Cynosure. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01754207, a NA study of Tattoos, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect further data on the safety and efficacy of removing unwanted non cosmetic tattoos (including recalcitrant) using the 755nm Alexandrite laser.
Primary Outcome
2D photography comparing pre and post treatment photos, where the percentage of tattoo clearance between the photos was determined by the evaluator.
Conditions Studied
Interventions
- DEVICE 755nm Alexandrite Laser
- DEVICE 755nm Alexandrite Laser with CAP Array
Study Locations (1)
Massachusetts
- Skin Care Physicians - Chestnut Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-01 |
| Phase | NA |
What the finished NCT01754207 record still lists
NCT01754207 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Tattoos appearing as the primary indexed condition, and to 2 interventions - of which 755nm Alexandrite Laser is the first listed.
NCT01754207 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01754207 about?
NCT01754207 is a clinical study titled "Evaluation of the 755nm Alexandrite Laser for the Treatment of Tattoos". The purpose of this study is to collect further data on the safety and efficacy of removing unwanted non cosmetic tattoos (including recalcitrant) using the 755nm Alexandrite laser.
What is the current status of trial NCT01754207?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2011-12. Estimated completion is 2014-01.
What conditions does trial NCT01754207 study?
This clinical trial studies the following conditions: Tattoos.
What interventions are being tested in trial NCT01754207?
The interventions under investigation include: 755nm Alexandrite Laser (DEVICE), 755nm Alexandrite Laser with CAP Array (DEVICE).
Who is sponsoring clinical trial NCT01754207?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01754207 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01754207's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia